Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) EBITDA (2023 - 2026)

Updated

Cero Therapeutics Holdings (CERO) recorded EBITDA of -$3.79 million in Q2 2026, compared with -$4.65 million a year earlier.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) EBITDA (2023 - 2026) Analysis & Trends

On a TTM basis, Cero Therapeutics Holdings' EBITDA came in at -$17.22 million as of Jun 30, 2026; for FY2025, it was -$18.18 million.

  • Across earlier years, EBITDA came in at -$14.9 million in FY2024 and -$7.21 million in FY2023.
  • The Q2 2026 figure is the highest quarterly EBITDA since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at -$4.78 million (Q1 2026), -$4.36 million (Q4 2025) and -$4.29 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.18 Mn
Mar 31, 2026 -4.65 Mn
Dec 31, 2025 -4.36 Mn
Sep 30, 2025 -4.29 Mn
Jun 30, 2025 -4.65 Mn
Mar 31, 2025 -4.87 Mn
Dec 31, 2024 -2.00 Mn
Sep 30, 2024 -4.29 Mn
Jun 30, 2024 -5.03 Mn
Mar 31, 2024 -3.58 Mn
Dec 31, 2023 -1.01 Mn
Sep 30, 2023 -1.42 Mn
Jun 30, 2023 -2.30 Mn
Mar 31, 2023 -2.32 Mn
API Access

Cero Therapeutics Holdings, Inc. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CERO&period=max&api_key=YOUR_API_KEY